Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|38|11-12|1405-1406

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.11-12, 2013-12, pp. : 1405-1406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1406-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn's colitis

By  

HISTOPATHOLOGY, Vol. 72, Iss. 4, 2018-03 ,pp. : 580-587

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: infliximab in severe ulcerative colitis – is it useful for all patients?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1413-1413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: infliximab in severe ulcerative colitis – is it useful for all patients? Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1413-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Squamous Cell Carcinoma of the Anal Transitional Zone after Ileal Pouch Surgery for Ulcerative Colitis: Systematic Review and Treatment Perspectives

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-01 ,pp. : 112-122

Karger

Access to resources Recommend Favorite